Marimed MRMD
OTC MRMD
$0.07 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Marimed (MRMD) EBIT Margin (2011 - 2026)

Marimed (MRMD) posted quarterly EBIT Margin of 0.32% for Q1 2026, up 272.0% year-over-year from 0.09% in Q1 2025, and up 102.91% quarter-over-quarter from 10.86% in Q4 2025.

Marimed (MRMD) EBIT Margin (2011 - 2026) Analysis & Trends

Marimed (MRMD) has reported EBIT Margin for 16 consecutive years, with 0.32% the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBIT Margin rose 272.0% year-over-year to 0.32%; the TTM figure through Mar 2026 stood at 1.03% (down 98.0% YoY), while the FY2025 annual figure was 1.76%, down 342.0% from the prior year.
  • EBIT Margin advanced to 0.32% in Q1 2026 per MRMD's latest filing, from 10.86% in the prior quarter.
  • Across five years, EBIT Margin topped out at 22.53% in Q1 2022 and bottomed at 10.86% in Q4 2025.
  • Historically, EBIT Margin has averaged 6.01% across 5 years, with a median of 5.33% in 2024.
  • On a YoY basis, EBIT Margin climbed as much as 475 bps in 2022 and fell as far as 2322 bps in 2022.
  • Marimed's EBIT Margin stood at 8.62% in 2022, then declined by 28 bps to 6.2% in 2023, then sank by 161 bps to 3.77% in 2024, then slumped by 188 bps to 10.86% in 2025, then soared by 103 bps to 0.32% in 2026.
  • Business Quant data shows MRMD's EBIT Margin at 0.32% in Q1 2026, 10.86% in Q4 2025, and 3.92% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -5.58%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 33.91%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 16.51%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 42.23%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 0.17%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 15.80%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 18.13%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Marimed 30.77 Mn 22.33 Mn 16.23 Mn 1.00%

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00%
Mar 31, 2026 0.32%
Dec 31, 2025 -10.86%
Sep 30, 2025 3.92%
Jun 30, 2025 2.88%
Mar 31, 2025 -2.40%
Dec 31, 2024 -3.77%
Sep 30, 2024 3.31%
Jun 30, 2024 2.36%
Mar 31, 2024 5.33%
Dec 31, 2023 6.20%
Sep 30, 2023 8.48%
Jun 30, 2023 9.71%
Mar 31, 2023 14.94%
Dec 31, 2022 8.62%
Sep 30, 2022 16.91%
Jun 30, 2022 13.63%
Mar 31, 2022 22.53%
Dec 31, 2021 3.88%
Sep 30, 2021 19.93%